Literature DB >> 22190277

Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delay.

Eric A Muller1, Swaroop Aradhya, Joan F Atkin, Erin P Carmany, Alison M Elliott, Albert E Chudley, Robin D Clark, David B Everman, Shannon Garner, Bryan D Hall, Gail E Herman, Emma Kivuva, Subhadra Ramanathan, David A Stevenson, David W Stockton, Louanne Hudgins.   

Abstract

Basal cell nevus syndrome (BCNS), also known as Gorlin syndrome (OMIM #109400) is a well-described rare autosomal dominant condition due to haploinsufficiency of PTCH1. With the availability of comparative genomic hybridization arrays, increasing numbers of individuals with microdeletions involving this locus are being identified. We present 10 previously unreported individuals with 9q22.3 deletions that include PTCH1. While 7 of the 10 patients (7 females, 3 males) did not meet strict clinical criteria for BCNS at the time of molecular diagnosis, almost all of the patients were too young to exhibit many of the diagnostic features. A number of the patients exhibited metopic craniosynostosis, severe obstructive hydrocephalus, and macrosomia, which are not typically observed in BCNS. All individuals older than a few months of age also had developmental delays and/or intellectual disability. Only facial features typical of BCNS, except in those with prominent midforeheads secondary to metopic craniosynostosis, were shared among the 10 patients. The deletions in these individuals ranged from 352  kb to 20.5  Mb in size, the largest spanning 9q21.33 through 9q31.2. There was significant overlap of the deleted segments among most of the patients. The smallest common regions shared among the deletions were identified in order to localize putative candidate genes that are potentially responsible for each of the non-BCNS features. These were a 929  kb region for metopic craniosynostosis, a 1.08  Mb region for obstructive hydrocephalus, and a 1.84  Mb region for macrosomia. Additional studies are needed to further characterize the candidate genes within these regions.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190277     DOI: 10.1002/ajmg.a.34216

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.

Authors:  Bertrand Isidor; Franck Bourdeaut; Delfine Lafon; Ghislaine Plessis; Elodie Lacaze; Caroline Kannengiesser; Sylvie Rossignol; Olivier Pichon; Annaig Briand; Dominique Martin-Coignard; Maria Piccione; Albert David; Olivier Delattre; Cécile Jeanpierre; Nicolas Sévenet; Cédric Le Caignec
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

2.  A novel INDEL mutation in the PTCH1 gene in a Chinese family with Gorlin syndrome.

Authors:  Zhuoya Huang; Yongan Zhou; Xiaoxia Fu; Aiping Kou; Hairong Fu; Han Xiao; Ying Jin; Zhonghua Zhao
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

3.  Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.

Authors:  Dinesh Kumar Sahu; Neetu Singh; Mumani Das; Jiledar Rawat; Devendra Kumar Gupta
Journal:  Pediatr Surg Int       Date:  2022-09-15       Impact factor: 2.003

Review 4.  Multidisciplinary approach to Gorlin-Goltz syndrome: from diagnosis to surgical treatment of jawbones.

Authors:  Francesco Spadari; Federica Pulicari; Matteo Pellegrini; Andrea Scribante; Umberto Garagiola
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-07-18

Review 5.  Infantile hydrocephalus: a review of epidemiology, classification and causes.

Authors:  Hannah M Tully; William B Dobyns
Journal:  Eur J Med Genet       Date:  2014-06-13       Impact factor: 2.708

6.  Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets.

Authors:  Iuliana Ionita-Laza; Vlad Makarov; Joseph D Buxbaum
Journal:  Am J Hum Genet       Date:  2012-05-10       Impact factor: 11.025

7.  Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data.

Authors:  D Matthew Gianferante; Melissa Rotunno; Michael Dean; Weiyin Zhou; Belynda D Hicks; Kathleen Wyatt; Kristine Jones; Mingyi Wang; Bin Zhu; Alisa M Goldstein; Lisa Mirabello
Journal:  Mol Genet Genomic Med       Date:  2018-11-08       Impact factor: 2.183

8.  Unexpected phenotype in a frameshift mutation of PTCH1.

Authors:  Benedetta Beltrami; Elisabetta Prada; Gianluca Tolva; Giulietta Scuvera; Rosamaria Silipigni; Daniela Graziani; Gaetano Bulfamante; Cristina Gervasini; Paola Marchisio; Donatella Milani
Journal:  Mol Genet Genomic Med       Date:  2019-10-02       Impact factor: 2.183

9.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

Review 10.  The Role of Hedgehog Signaling in Tumor Induced Bone Disease.

Authors:  Shellese A Cannonier; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2015-08-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.